Health care stocks were edging higher premarket Monday as the Health Care Select Sector SPDR Fund (XLV) was advancing by 0.2% and the iShares Biotechnology ETF (IBB) was recently up 0.3%.
Amneal Pharmaceuticals (AMRX) shares were up more than 3% after the company said it expects to report Q2 income before taxes of $45 million to $56 million, compared with $20 million a year earlier.
Evotec (EVO) shares were down nearly 13% after the company lowered its fiscal 2025 revenue guidance to reflect a shift in the revenue mix.
Sarepta Therapeutics (SRPT) shares were nearly 10% lower after the company said in a regulatory filing the US Food and Drug Administration has placed a clinical hold on its gene therapy trials for limb-girdle muscular dystrophy.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.